Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis

Journal of Hepatology

Volumn 40, Issue 5, 2004, Pages 781-786

  Namikawa, Chikako ^a   Shu Ping, Zhang ^a   Vyselaar, John Raynor ^a   Nozaki, Yasuko ^a   Nemoto, Yoshihisa ^a   Ono, Masafumi ^a   Akisawa, Naoaki ^a   Saibara, Toshiji ^a   Hiroi, Makoto ^a   Enzan, Hideaki ^a   Onishi, Saburo ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

4 Hydroxy 2 nnoneal; A, Alanine; BMI, body mass index; Body mass index; C, cytosine; G, guanine; HCV, hepatitis C virus; HNE, 4 hydroxy 2 nonenal; Manganese superoxide dismutase; Non alcoholic steatohepatitis; Oxidative stress; Radical oxygen species

Indexed keywords

FAT; MANGANESE SUPEROXIDE DISMUTASE; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN;

ADULT; ALLELE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS; HUMAN; HUMAN TISSUE; INCIDENCE; LIVER; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MANGANESE SUPEROXIDE DISMUTASE GENE; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN GENE; NONALCOHOLIC FATTY LIVER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS;

ADULT; ALDEHYDES; ALLELES; BASE SEQUENCE; CARRIER PROTEINS; CASE-CONTROL STUDIES; DNA; FATTY LIVER; FEMALE; GENE FREQUENCY; HEPATITIS, CHRONIC; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SUPEROXIDE DISMUTASE; SYNDROME;

EID: 11144356355     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.01.028     Document Type: Article

References (32)

1. Farrell G.C. Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region? J Gastroenterol Hepatol. 18:2003;124-138.
2. Day C.P., James O.F.W. Steatohepatitis: a tale of two 'hits'? Gastroenterology. 114:1998;842-844.
3. Day C.P., Saksena S. Non-alcoholic steatohepatitis: definitions and pathogenesis. J Gastroenterol Hepatol. 17:2002;S377-S384.
4. Perlemuter G., Sabile A., Letteron P., Vona G., Topilco A., Chretien Y., et al. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. Fed Am Soc Exp Biol J. 16:2002;185-194.
5. Wetterau J.R., Lin M.C., Jamil H. Microsomal triglyceride transfer protein. Biochim Biophys Acta. 1345:1997;136-150.
6. Partin J.S., Partin J.C., Schubert W.K., McAdams A.J. Liver ultrastructure in abetalipoproteinemia: evolution of micronodular cirrhosis. Gastroenterology. 67:1974;107-118.
7. Au W.S., Kung H.F., Lin M.C. Regulation of microsomal triglyceride transfer protein gene by insulin in HepG2 cells. Roles of MAPK/erk and MAPK/p38. Diabetes. 52:2003;1073-1080.
8. Karpe F., Lundahl B., Ehrenborg E., Eriksson P., Hamsten A. A common functional polymorphism in the promoter region of the microsomal triglyceride transfer protein gene influences plasma LDL levels. Arterioscler Thromb Vasc Biol. 18:1998;756-761.
9. Bernard S., Touzet S., Personne I., Lapras V., Bondon P.J., Berthezene F., et al. Association between microsomal triglyceride transfer protein gene polymorphism and the biological features of liver steatosis in patients with type II diabetes. Diabetologia. 43:2000;995-999.
10. Letteron P., Fromenty B., Terris B., Degott C., Pessayre D. Acute and chronic steatosis lead to in vivo lipid peroxidation in mice. J Hepatol. 24:1996;200-208.
11. Letteron P., Duchatelle V., Berson A., Fromenty B., Fisch C., Degott C., et al. Increased ethane exhalation, an in vivo index of lipid peroxidation, in alcohol-abusers. Gut. 34:1993;409-414.
12. Wispe J.R., Clark J.C., Burhans M.S., Kropp K.E., Korfhagen T.R., Whitsett J.A. Synthesis and processing of the precursor for human mangano-superoxide dismutase. Biochim Biophys Acta. 994:1989;30-36.
13. Mitrunen K., Sillanpaa P., Kataja V., Eskelinen M., Kosma V.M., Benhamou S., et al. Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk. Carcinogenesis. 22:2001;827-829.
14. Stewart S.F., Leathart J.B., Chen Y., Daly A.K., Rolla R., Vay D., et al. Valine-alanine manganese superoxide dismutase polymorphism is not associated with alcohol-induced oxidative stress or liver fibrosis. Hepatology. 36:2002;1355-1360.
15. Brunt E.M., Janney C.G., Di Bisceglie A.M., Neuschwander-Tetri B.A., Bacon B.R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 94:1999;2467-2474.
16. Brunt E.M. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis. 21:2001;3-16.
17. Murata Y., Ogawa Y., Saibara T., Nishioka A., Takeuchi N., Kariya S., et al. Tamoxifen-induced non-alcoholic steatohepatitis in patients with breast cancer: determination of a suitable biopsy site for diagnosis. Oncol Rep. 10:2003;97-100.
18. Shimoda-Matsubayashi S., Matsumine H., Kobayashi T., Nakagawa-Hattori Y., Shimizu Y., Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Biophys Res Commun. 226:1996;561-565.
19. Hiroi S., Harada H., Nishi H., Satoh M., Nagai R., Kimura A. Polymorphisms in the SOD2 and HLA-DRB1 genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese. Biochem Biophys Res Commun. 261:1999;332-339.
20. Van Landeghem G.F., Tabatabaie P., Kucinskas V., Saha N., Beckman G. Ethnic variation in the mitochondrial targeting sequence polymorphism of MnSOD. Hum Hered. 49:1999;190-193.
21. Saadeh S., Younossi Z.M., Remer E.M., Gramlich T., Ong J.P., Hurley M., et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 123:2002;745-750.
22. Chitturi S., Farrell G.C. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis. 21:2001;27-41.
23. Alameddine F.M., Zafari A.M. Genetic polymorphisms and oxidative stress in heart failure. Congest Heart Fail. 8:2002;157-164.
24. Stoehlmacher J., Ingles S.A., Park D.J., Zhang W., Lenz H.J. The -9Ala/-9Val polymorphism in the mitochondrial targeting sequence of the manganese superoxide dismutase gene (MnSOD) is associated with age among Hispanics with colorectal carcinoma. Oncol Rep. 9:2002;235-238.
25. Mattey D.L., Hassell A.B., Dawes P.T., Jones P.W., Yengi L., Alldersea J., et al. Influence of polymorphism in the manganese superoxide dismutase locus on disease outcome in rheumatoid arthritis: evidence for interaction with glutathione S-transferase genes. Arthritis Rheum. 43:2000;859-864.
26. Nomiyama T., Tanaka Y., Piao L., Nagasaka K., Sakai K., Ogihara T., et al. The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients. J Hum Genet. 48:2003;138-141.
27. Ambrosone C.B., Freudenheim J.L., Thompson P.A., Bowman E., Vena J.E., Marshall J.R., et al. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res. 59:1999;602-606.
28. Pessayre D., Mansouri A., Fromenty B. Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis. Am J Physiol Gastrointest Liver Physiol. 282:2002;G193-G199.
29. Monto A., Alonzo J., Watson J.J., Grunfeld C., Wright T. Steatosis in chronic hepatitis C: relative contribution of obesity, diabetes mellitus, and alcohol. Hepatology. 36:2002;729-736.
30. Perlemuter G., Sabile A., Letteron P., Vona G., Topilco A., Chretien Y., et al. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. Fed Am Soc Exp Biol J. 16:2002;185-194.
31. Pinto H.C., Baptista A., Camilo M.E., de Costa E.B., Valente A., de Moura M.C. Tamoxifen-associated steatohepatitis - report of three cases. J Hepatol. 23:1995;95-97.
32. Nemoto Y., Toda K., Ono M., Adachi K., Saibara T., Onishi S., et al. Altered constitutive expression of fatty acid-metabolizing enzymes in aromatase-deficient (ArKO) mice. J Clin Invest. 105:2000;1819-1825.